Please login or sign up to post and edit reviews.
Sandoz Inc. v. Amgen Inc. - Publication Date |
- Apr 26, 2017
- Episode Duration |
- Unknown
A case in which the Court determined that the Biologics Price Competition and Innovation Act of 2009 allows for commercial notice of a “biosimilar product” to be effective if given prior to approval by the Food and Drug Administration (FDA), but that the Act’s notice requirement is not enforceable with an injunction.
This episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review